given prgo delay earn guidanc postpon april
may consensu number think high
unreserv tax assess overhang approxim billion
recent histori accur set guidanc asset may
difficulti divest gener remain sidelin
share believ stock declin significantli
ep share reflect risk met
new ceo mid-decemb recent caught
investor relat believ narr continu evolv
plan increas invest innov may come
expens near-term earn new plan unveil
april/may believ difficult see share
outperform believ guidanc may serv catalyst
question whether consensu assumpt modest
ep growth correct overal share reflect lot
neg news ep estim drop significantli
past three month novemb today consensu
drop vs estim
certain next updat increment posit
recal recent file late decemb
indic receiv notic assess noa irish
offic revenu commiss irish revenu approxim
billion indic know tax
assess final said believ
approxim outstand noa irish revenu
far largest assess larger
other combin state lose appeal
believ irish author would requir up-front
immedi payment would work find payment solut
indic investor feedback new ceo plan
expand healthcar self-car transit posit
investor look hear manifest real
term announc last week jame dillard
appoint execut vice presid chief scientif offic
dillard join altria group inc serv
senior vice presid research develop scienc
multi-year basi might well trust ceo not-
yet-rev plan prefer hear detail first
indic earlier maintain market perform rate
share price target
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
report non-gaap adjust ep exclud one-tim item
compani data secur llc estim reuter
price target nc
price target base dcf valuat includ discount rate termin
multipl integr larg part outlook carri substanti risk
risk includ turnaround brand consum healthcar busi weak rx
pharmaceut irish tax disput
believ share perform market evid emerg recent
turnaround durabl particularli relat eu busi gener busi
recent under-perform
began packag gener home remedi year later one top
over-the-count over-the-counter consum good product compani market share privat label
store brand also among lead compani pharmaceut gener market
well activ pharmaceut ingredi api market
